Schizophrenia Clinical Trials

Showing 1121-1140 of 1,356 trials

Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia

NCT00768612

This study will evaluate the clinical safety and tolerability of vabicaserin in Japanese subjects that have a sudden worsening of their symptoms of schizophrenia. The study will also assess the efficacy of vabicaserin and compare it to risperidone.

Schizophrenia

Wyeth is now a wholly owned subsidiary of PfizerStarted Nov 2008

TERMINATEDPhase 2/3

A Long-Term, Open-Label, Study on Schizophrenia

NCT01129674

The primary purpose of the study is to help answer the following research questions: How LY 2140023 can be tolerated by patients with Schizophrenia compared to standard of care treatment in 52 weeks time period. Whether LY 2140023 can help patients with Schizophrenia.

Schizophrenia

Eli Lilly and Company1,210 participantsStarted Jun 2010

Little Rock, Arkansas, United States • Escondido, California, United States • Garden Grove, California, United States +78 more locations

Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia

A Long-Term, Open-Label, Study on Schizophrenia

Related Searches

Effects of Motivating People With Schizophrenia to Exercise

Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder

Naltrexone Treatment of Alcohol Abuse in Schizophrenia

Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia

CAFE Comparison of Atypicals in First Episode of Psychosis

Seroquel on Glucose Metabolism

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

rTMS Effects on Smoking Cessation and Cognition in Schizophrenia

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

Different Safety Profile of Risperidone and Paliperidone Extended-release

A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia

A Long-Term Study of JNS007ER in Patients With Schizophrenia